Inventor profile of:

Christopher M. Semko

City:

Fremont, California

Country:

United States

Published Applications:

31

Last publication date:

2014-03-13

Top Assignees for applications by Christopher M. Semko

The entities that hold a legal rights for patent applications filed by inventor Semko Christopher M.:

Recent patent applications by Semko Christopher M.

Christopher M. Semko from Fremont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-03-13
US20140073788A1
Chemistry; metallurgy

Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds

#2 | 2013-12-19
US20130338164A1
Human necessities

Multimeric VLA-4 Antagonists Comprising Polymers Moieties

#3 | 2013-01-17
US20130018187A1
Chemistry; metallurgy

Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds

#4 | 2012-12-27
US20120329807A1
Human necessities

Multimeric VLA-4 Antagonists Comprising Polymers Moieties

#5 | 2011-07-21
US20110178119A1
Chemistry; metallurgy

Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase

#6 | 2011-01-06
US20110003802A1
Chemistry; metallurgy

Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase

#7 | 2011-01-06
US20110002876A1
Human necessities

Multimeric VLA-4 antagonists comprising polymer moieties

#8 | 2010-10-21
US20100267747A1
Chemistry; metallurgy

5-(Arylsulfonyl)-Pyrazolopiperidines

#9 | 2010-04-01
US20100081680A1
Chemistry; metallurgy

N-sulfonamido polycyclic pyrazolyl compounds

#10 | 2008-04-17
US20080090817A1
Chemistry; metallurgy

Bridged N-cyclic sulfonamido inhibitors of gamma secretase

#11 | 2008-01-24
US20080021056A1
Chemistry; metallurgy

Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase

#12 | 2008-01-22
US10316205
-

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

#13 | 2007-10-30
US10119238
-

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

#14 | 2007-07-05
US20070155753A1
Chemistry; metallurgy

5-(arylsulfonyl)-pyrazolopiperidines

#15 | 2007-03-01
US20070049612A1
Chemistry; metallurgy

Bridged N-cyclic sulfonamido inhibitors of gamma secretase

#16 | 2007-02-15
US20070037804A1
Chemistry; metallurgy

Imidazolone phenylalanine derivatives

#17 | 2007-02-01
US20070027131A1
Chemistry; metallurgy

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

#18 | 2007-01-25
US20070021555A1
Chemistry; metallurgy

Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds

#19 | 2006-04-18
US9126096
-

Compounds which inhibit leukocyte adhesion mediated by VLA-4

#20 | 2006-04-11
US10447308
-

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

#21 | 2006-03-07
US10447208
-

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

#22 | 2006-01-19
US20060013799A1
Human necessities

Multimeric VLA-4 antagonists comprising polymer moieties

#23 | 2005-10-27
US20050238614A1
Chemistry; metallurgy

Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids

#24 | 2005-10-06
US20050222119A1
Human necessities

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

#25 | 2005-09-29
US20050215565A1
Human necessities

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

#26 | 2005-09-01
US20050192280A1
Chemistry; metallurgy

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

#27 | 2005-06-16
US20050130999A1
Chemistry; metallurgy

Heteroaryl compounds which inhibit leukocyte adhesion mediated by αintegrins

#28 | 2005-06-02
US20050119290A1
Chemistry; metallurgy

Heterocyclic compounds which inhibit leukocyte adhesion mediated by αintegrins

#29 | 2005-05-31
US9987619
-

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

#30 | 2005-04-21
US20050085459A1
Chemistry; metallurgy

Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

#31 | 2005-03-31
US20050069541A1
Human necessities

Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents

InventorID:

42907